ArticleThe Journal of clinical investigation2021

Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma.

Aviyah Peri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.